CDA @ISPOR Annual 2026

ISPOR Annual Meeting 

Philadelphia, PA, May 17-20, 2026

Find CDA at Booth # 511

• Monday 9:30 AM-7:00 PM
• Tuesday 9:30 AM-7:00 PM
• Wednesday 8:30 AM-11:30 AM

Meet the team and learn about our 17 presentations.

Monday, May 18

PODIUM PRESENTATION, 10:30-11:30 AM

• P5: Real-world effectiveness of anti-obesity pharmacotherapy in Medicare: Integrated 100% Fee-For-Service claims and EMR analysis of BMI reduction and cardiovascular outcomes

ONCOLOGY POSTER TOUR, 11:30 AM-12:15 PM

• PT6: Targeted therapy, immunotherapy, and molecular testing in advanced solid tumors: A 2021–2025 Medicare analysis

Poster Session 1 Discussion: 12:30-1:30 PM

• MSR7: Early identification of postpartum depression risk using artificial intelligence   

• CO21: Real-world impact of anti-amyloid therapy in Alzheimer’s disease: An integrated analysis of 100% Medicare FFS claims linked with laboratory, electronic medical records, and patient-reported outcomes measures

Poster Session 2 Discussion: 6-7 PM

• MSR69: Modeling rare events in health intervention: An application from the Department of War dataset

Tuesday, May 19

Poster Session 3 Discussion: 12:30-1:30 PM

• CO106: Real-world safety and outcomes of bispecific antibodies in older adults

• CO88: Real-world impact of modern obesity pharmacotherapy on liver outcomes in Medicare-Enhanced Lab and Demographics data: 2021–2025 

• EPH113: Projected impact of personalized mRNA neoantigen cancer vaccines in Medicare: A scenario analysis using trial efficacy and linked data population estimates

• EE277: Healthcare resource use in rare disease clinical trials: A systematic review TOP 5% FINALIST

Poster Session 4 Discussion: 6-7 PM

• CO143: Real-world perioperative immunotherapy and cellular therapy in older adults with solid tumors: A 2021–2025 Medicare-EMR linked analysis TOP 5% FINALIST

• CO144: Real-world multiple myeloma treatment responses: Evaluation of frontline regimens in MELD TM linked Medicare, laboratory and electronic medical records

• EPH143: Prevalence and incidence of obesity and budget impact of the MOVE! Weight Management Program in US veterans

• CO153: Laboratory markers and short-term outcomes in respiratory syncytial virus among older adults: Medicare-Enhanced and Laboratory Data analysis 2021–2025

Wednesday, May 20

Poster Session 5 Discussion: 9-10 AM

• CO175: Comparative risk of suicidal ideation and self-harm among patients with major depressive disorder treated with brexpiprazole vs other oral atypical antipsychotics: A propensity score–matched cohort analysis

• HPR139: Inflation Reduction Act “pill penalty” and small-molecule innovation: Signals from investment, pipelines, and post-approval research

• CO186: Treatment patterns and gaps in resectable mucosal melanoma care for Medicare beneficiaries in the United States

• CO189: Timing of serious adverse events following mifepristone abortion in US commercial and Medicaid populations

Learn more about ISPOR.

Find more CDA presentations and publications here.